Member Info for Pingu777

I’m fairly eloquent yet I can’t think of a single word to describe this bb. The state of it is just comedy. Anyone reading this simply please do not take any action as a result of what you have read tonight on here.

Now I don’t post about SYME as I’m still researching.

But the RNS updates are quite clear in the progress being made. Hoping for further details this week from the CEO and see vast potential here.

The CEOs desperation to constantly tell us ‘more news soon’ seems a bit naive and desperate. However, I have little reason to doubt wheels are in motion as referred. Now the next few updates will confirm or deny said progress and a further review of my position will follow mid October.

Plenty of deramper action is quite reassuring to be honest.

Don’t want to seem harsh but what do you expect? Pharma takes time to make progressive steps that require RNSing. HEMO has amazing tech and is still so cheap to get into. Vlad does not RNS to keep PIs happy with ‘regular’ passifying meaningless updates.

Surely you get that work is ongoing and they’re busy even though it’s quiet RNS-wise?

Why did you invest in the first place?

Just hold people. Literally shareholders need to do nothing for a year. Big surges much sooner but just literally do nothing. It’s not hard. We can do this. I’m off for a snack. Peace out

I can’t be bothered to post on here for a while. But pumpky you make me wanna puke! It’s an irrational response I think to the previous BS you spouted but I just hope you sell out soon so you don’t profit from HEMO. Good luck.

Investors need patience and patients to see the phase 2 trials through to conclusion.

Not long now...

The SPs taken a dusting. No doubt. Doesn’t make the things you suggest correct.

How do you see the SP towards the end of September where the CEO had said he’ll be updatIng the market on a number of areas? How about this time next year?

You’re already five bags up. Easy ride for trend setters like you who see things so early!

This thread should be dramatised by ITV haha

Lots of lying and misleading going on. Sit back and hold for a few weeks and see if Alissandro delivers what he suggests by the end of Sept. you’ll be a better position whether to hold long term or not then. Seems a no brainer to me. Strong news just around the corner.

Nice post QuickDraw.

And just for clarity Sir Marc Feldmann said these two things in the 30/4 years end chairman’s statement:

“The Board has continued to demonstrate its confidence in the ongoing success of the business throughout the period under review and post-period end. I have elected to receive most of my remuneration in share options and collectively we remain confident that the Company's shares should deliver significant shareholder return over the long term.”
“My fellow Directors and I are greatly encouraged by the Company's work and on-going conversations with key industry partners on several fronts, and believe that the next 12 months will mark a key inflection point in its growth and maturity.”

- significant share holder returns
-next 12 months a key inflection point for the company (since April)

So do I trust Sir Feldmann and his CV, or some clown on here who doesn’t even know what CDX is?

Sorry auto correct text on the phone is tosh.
Bye.

Tumbleweed.

People come on here and **** hemo off and it’s posters.

Share holders need to keep faith in the next gen treatments, drug testing platform and serious partners.

Time is our friend and the clock is ticking. Vlad makes progress every day. Maybe not at the speed many would prefer but every day is a small step forward.

We cannot predict the short term SP. impossible to claim to be able to do so. Any estimate is merely a guess. But by the end of the year, Q1, Q2 next year... the magnificence of Vlad and his colleagues work will unfold. Maybe blood cancer bad disease sufferers will be surging longer. And little old HEMO won’t be stopped.

Eli take over has a strong possibility. We all know their quarterly business purchase budget. So what is a ground breaking AML cure worth? A chemo replacement? A fast track drug testing platform That will validated with a successful CDX phase one human trials.

The story is compelling. The doubters and derampers literally cannot infer a single point of past failure to cast doubt on HEMOs next steps. They have zero, zilch to say. No facts. As there are none.

Investors sit back and relax. Let HEMO do the hard work for us. Be patient people and trust your research.

G’night

Come on pumpky. Share with us your wealth of knowledge about the tripe you’re comparing to HEMO. No copy and paste mind. I want some insight into your research and understanding of the pharmas you buy.

I’d be interested to know which of their products compares to one of ours and how it is superior?

Very open to any insight you’ve got for us.

Pumpky you misunderstand. I want you to explain it to me.

No one daft enough to in REAT surely?

Dave. Tell me what worries about HEMO? Which bits do you not see reaching their goals? Products not good enough? Discovery platform too basic? Or is it all a bit too much for you?

And you wanted back in the 6s or 7s I recall pumper when it was in the 9s? 10.4p is not down my friend. It’s only going one way. You can feel the unstoppable force of inevitability of HEMOs rise to its destiny. Every day that passes and you post your drivel on here HEMO moves closer saving lives.

If you think the SP is high now you should short it. If you think it is low then it represents value, surely? So what’s your play stumpy pumpy? Xx

Tell me about what SCLP do pumper? I’m intrigued. What they working on? For what disease? What’s the treatment based upon?

Arthur,
You have invested in a pharma junior. You have cited no news for a few weeks. This is standard.

Hemogenyx is the best 12-18months bet in the markets today.

We rose over 50% on no news. No aspersions were cast - no hard questions asked. We drop 30% and its doom and gloom. Basically nothing has changed throughout the whole roller coaster of a week or so.

You need to set some realistic expectations.

My Dad used to say if you were in a conversation Ona subject you didn’t know much about it was best to keep quiet. Have them think you could be an idiot rather than speak and confirm it.

Stick with your conviction people. Both nice investment people, well done.

HEMO is at the front edge of drug innovation both in their development of candidate and in their development platform for antibody based drugs and drug modelling using the ApbCH.

They have a double edged sword. Next gen drugs and next gen testing capacity.

I’ve gone on a bit in the past about HEMO. But I hold the same conviction as Chad. HEMO is the real deal. This is the beginning of the inflection period In the SP and HEMOs total transformation into a life saving company.

How on Earth they drilling down the SP? Has to be total MM work this. Unless they’re holding back big print sells.

But trading looks askew with the SP movements.

The prospectus will open DEV up to further institutional investors. The timing of the issue of the prospectus would be well planned if released just before big news on roll out take up numbers and some income info. The perfect storm. We’re slowly heading to the launchpad. Cape Canaveral holds its breath... ;-)

People just need to do be comfortable with their decision to invest and why. Fundamentals are 99% the name of the game. Finance, management team, market to sell into, USP, income structure, market timing, sentiment etc

But sometimes there comes along a springer tech play that ticks none of the ‘normal’ boxes. I’d say opportunity, timing and sentiment are the biggies here. Just stay sensible people and don’t over invest. Bit imo this could have some serious legs. Let’s see where we are in a week or two.